Skip to content

Molecular Response After Concurrent Exercise With Low Glycogen

The Effects of Glycogen Availability on the Skeletal Muscle Molecular Response After Concurrent Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02668445
Acronym
Glyconcurrent
Enrollment
14
Registered
2016-01-29
Start date
2015-11-30
Completion date
2016-04-30
Last updated
2018-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Concurrent, muscle, glycogen, molecular

Brief summary

This is a randomized, counterbalanced crossover design, in which 14 male subjects will complete two experimental trials. Each trial will be separated by a minimum of at least 12 days (range: 12-30 days). The study aims to investigate the effects of low glycogen availability on skeletal muscle molecular response after a concurrent exercise day.

Detailed description

Two experimental exercise trials; a low carbohydrate (= LOW) and a high carbohydrate (= HIGH) trial. During both experimental days subjects will complete an continues submaximal cycling bout in the morning followed by a resistance exercise session in the early afternoon. During the LOW trial subjects will receive a low carbohydrate mixed meal, during the HIGH trial subjects will be provided with a high carbohydrate meal. In addition, on both experimental days subjects will receive adequate protein beverages. Lastly, protein will be provided post resistance exercise.

Interventions

OTHERStandard meal containing low or high carbohydrate content

Sponsors

Wageningen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Male gender between 18 and 30 years of age * BMI between 18.5 - 25 kg/m2 * Participating in regular exercise training (at least 1 exercise session, and a maximum of 3 exercise session per week) * Used to different types of exercise (endurance, resistance and/or concurrent) * Willing to give blood samples * Willing to give muscle biopsies * No use of antibiotics during the study or in the past month * No drug use * Suitable veins for blood withdrawal * Registered by a general-practitioner * Consumption of alcohol beverages is less than 21 per week * No blood donor during the study * No vegetarian and willing to eat meat during the experimental days * Able to be present and participate at both test days and pre testing moments * Not employed, or intern, or working on thesis at the department of Human Nutrition at Wageningen University * Not participating in another scientific study (except EetMeetWeet) * Able to participate during the experimental days en pre tests * Able to speak Dutch

Exclusion criteria

* Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, pulmonary disease, gluten intolerance) * Systolic blood pressure \>160 mmHg and/or diastolic blood pressure \>100 mmHg * Use of medications known to interfere with gene expression in the muscles (i.e. statins, fenofibrate) * Use of antithrombotic therapy (marcoumar, sintromitis). * Diagnosed diabetes mellitus type 1 or 2 * (Chronic) injuries of the locomotor system that can interfere with the intervention

Design outcomes

Primary

MeasureTime frame
Proteins involved in hypertrophy10 hours

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026